Imagine having the ability to...
Our artificial vision technology has the potential to make this a reality for profoundly blind people around the world
Second Sight’s legacy product, Argus® II, approved by the FDA for the treatment of retinitis pigmentosa, has been implanted in 350+ individuals worldwide, restoring functional, artificial vision by renewing light perception and transforming the daily experience in the majority of individuals.
Authorized by Federal (U.S.) law to provide electrical stimulation of the retina to induce visual perception in blind patients with severe to profound retinitis pigmentosa and bare light or no light perception in both eyes. The effectiveness of this device for this use has not been demonstrated.
Building on over 20 years of research
Our world-class scientific and engineering staff continue to innovate, inspired by our deep focus on enhancing the lives of the visually impaired. Our next-generation product, the Orion® Visual Cortical Prosthesis System, is an investigational device intended to bring artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, or forms of cancer and trauma.
CAUTION – Investigational Device. Limited by Federal (United States) law to investigational use.